First-generation antipsychotics: movement effects, NMS and anticholinergic care

Why dopamine blockade causes movement side effects

Typical antipsychotics reduce psychotic symptoms by blocking dopamine D2 receptors. The same blockade in the motor pathways of the basal ganglia upsets the balance that keeps movement smooth, which is why this class carries a higher likelihood of involuntary movement disorders than second-generation agents. Potency matters: high-potency drugs such as haloperidol are more strongly linked to movement effects.

Lower-potency drugs such as chlorpromazine block more histamine, alpha-adrenergic and muscarinic receptors. Expect more sedation, orthostatic hypotension and anticholinergic effects with them. Anticholinergic effects include dry mouth, blurred vision, constipation and difficulty urinating, and phenothiazines can also cause sun sensitivity and dizziness on standing. Knowing the profile helps predict which complaint matters most.

Recognising the four extrapyramidal patterns

Acute dystonia appears early as sustained muscle spasm: neck twisting, eyes rolling upward or a protruding tongue. Laryngeal involvement threatens the airway, so it is urgent; the prescriber usually orders an anticholinergic or antihistamine medicine to reverse it. Akathisia is an inner restlessness with pacing and inability to sit still, easily mistaken for worsening agitation. Drug-induced parkinsonism brings a blank facial expression, shuffling gait, tremor and rigidity.

Tardive dyskinesia develops later, often as lip smacking, chewing, worm-like tongue movements or limb writhing. Screen at baseline and at regular intervals using a structured involuntary-movement rating scale under local policy, because subtle signs are easy to miss in conversation. Report new movements rather than treating them as habits, because tardive dyskinesia may persist or even worsen after the drug is stopped; early detection gives the prescriber the best chance to adjust the regimen.

Document movement findings in plain descriptive terms, such as the body part, the type of movement and when it started, rather than a single label. A clear baseline lets the next nurse recognise a change, and it gives the prescriber the detail needed to decide whether dose reduction, a switch or additional treatment is appropriate.

Neuroleptic malignant syndrome as a medical emergency

Neuroleptic malignant syndrome combines altered mental status, severe muscle rigidity, high temperature and autonomic instability such as tachycardia, labile blood pressure and sweating. Creatine kinase may be raised, and rigidity can lead to rhabdomyolysis. It is uncommon but serious, and patients are taught to report fever with stiff muscles, confusion or a fast, irregular heartbeat immediately.

The nurse withholds the antipsychotic and escalates urgently. Treatment is supportive, with cooling, fluids, electrolyte correction and, as prescribed, medicines such as dantrolene, lorazepam or bromocriptine. Track temperature, mental status, urine output and colour. Distinguish it from simple fever: rigidity, confusion and autonomic swings together point to the syndrome rather than routine infection.

Cardiac, safety and teaching priorities

Several antipsychotics, including haloperidol, can prolong the QT interval and raise the risk of dangerous arrhythmias. Ask about personal or family history of prolonged QT, review interacting medicines, and report palpitations or fainting. Older adults with dementia-related psychosis have increased mortality with antipsychotics, and haloperidol is not approved for behaviour problems in dementia.

Teach patients to rise slowly, use sunscreen and protective clothing, sip water or use sugar-free gum for dry mouth, and report difficulty urinating or constipation. Advise caution with driving until the sedative effect is known and avoid alcohol. Encourage the patient to report restlessness honestly, since akathisia is a common reason people stop treatment without telling anyone.

Worked exam-style scenario

Imagine a hypothetical young adult who received haloperidol yesterday and now has the neck twisted to one side, eyes deviated upward and difficulty speaking. Options include documenting a behavioural outburst, offering reassurance, giving the next scheduled antipsychotic dose, or treating this as acute dystonia and escalating promptly for prescribed treatment, such as an anticholinergic, while watching the airway.

Escalating is the strongest answer because acute dystonia appears early after a high-potency drug and can involve the larynx. Labelling it behaviour delays treatment, and giving another dose worsens the cause. Change the facts to fever, rigidity and confusion after a week of therapy, and the priority shifts to suspected neuroleptic malignant syndrome, with the drug held.

Sources and further reading

MedlinePlus: Haloperidol. Anticholinergic and movement side effects, NMS warning symptoms, QT history and dementia mortality warning.

MedlinePlus: Tardive dyskinesia. Tardive dyskinesia features, link to antipsychotic use, and movements that may become permanent or worsen even after the medicine is stopped.

MSD Manual Professional: Schizophrenia. First- versus second-generation classification, movement disorder risk, dystonia, parkinsonism, akathisia and QT prolongation.

MSD Manual Professional: Neuroleptic malignant syndrome. Clinical features, raised creatine kinase, rhabdomyolysis and supportive treatment including dantrolene, lorazepam and bromocriptine.